New Releases from NCBI BookshelfCipaglucosidase alfa with miglustat for treating late-onset Pompe disease.Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease.
Post Content
Post Content
End-of-life (EOL) care planning in patients with end-stage renal disease (ESRD) is a necessity, but this preparation occurs infrequently and